FDA studying if gel for diabetic ulcers causes cancer

Article

Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.

Is Regranex (becaplermin, Johnson & Johnson) Gel, which helps heal foot and leg diabetic ulcers, associated with higher rates of cancer death? That?s what the Food & Drug Administration is now studying. In an early company.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, clickhere.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.